Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Xiaoqun Dong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7253-869X; OpenAlex author ID A5059632884. Sources: OpenAlex.

Their work

Papers
17 (first author 1, last author 6)
Trials
0
Grants
0
Labs led
2
Collaborators
32
Papers, trials and grants by year

2011: 4 papers · 2012: 3 papers · 2013: none · 2014: 4 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 3 papers

Papers 17

  1. Corrigendum to "Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma" [Cancer Lett. 449 (2019) … Co-author DOI 10.1016/j.canlet.2025.218118↗
  2. Corrigendum to "Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis" [Cancer Lett. 481 (2020) 63-75]. Last author DOI 10.1016/j.canlet.2025.218119↗
  3. Corrigendum to "LRH1 promotes pancreatic cancer metastasis" [Cancer Lett. (2014) 24 350 (1-2) 15-24]. Last author DOI 10.1016/j.canlet.2026.218518↗
  4. Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis. Last author DOI 10.1016/j.canlet.2020.02.039↗
  5. Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2019.02.006↗
  6. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Last author DOI 10.1186/s13045-019-0837-z↗
  7. LRH1 as a driving factor in pancreatic cancer growth. Last author DOI 10.1016/j.canlet.2013.11.014↗
  8. LRH1 promotes pancreatic cancer metastasis. Last author DOI 10.1016/j.canlet.2014.04.017↗
  9. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer. Co-author DOI 10.1371/journal.pone.0085942↗
  10. Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer. Co-author DOI 10.7150/jca.10094↗
  11. DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer. Co-author DOI 10.1002/mc.20817↗
  12. Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer. Co-author DOI 10.1016/j.canep.2011.05.013↗
  13. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Co-author DOI 10.1093/carcin/bgs151↗
  14. Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer. Co-author DOI 10.1002/cncr.25612↗
  15. Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer. First author DOI 10.1158/1055-9965.epi-10-0845↗
  16. Glucose metabolism gene variants modulate the risk of pancreatic cancer. Co-author DOI 10.1158/1940-6207.capr-10-0247↗
  17. DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer. Co-author DOI 10.1634/theoncologist.2010-0127↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jack R. Wands · 8 shared papers, 2014–2026 · strength 1.10
  2. Qiushi Lin · 6 shared papers, 2014–2026 · strength 0.74
  3. Xuewei Bai · 5 shared papers, 2019–2026 · strength 0.74
  4. Katsuya Nagaoka · 5 shared papers, 2019–2026 · strength 0.74
  5. Kosuke Ogawa · 5 shared papers, 2019–2026 · strength 0.74
  6. Lianxin Liu · 3 shared papers, 2019–2026 · strength 0.38
  7. Rui Kong · 3 shared papers, 2019–2026 · strength 0.38
  8. Le Li · 3 shared papers, 2019–2026 · strength 0.38
  9. Howard P. Safran · 3 shared papers, 2019–2026 · strength 0.38
  10. Min Li · 2 shared papers, 2019–2026 · strength 0.30
  11. Donghui Li · 7 shared papers, 2011–2014 · strength 0.25
  12. Yongwei Wang · 1 shared paper, 2026 · strength 0.22
  13. James L. Abbruzzese · 6 shared papers, 2011–2012 · strength 0.20
  14. Kenneth R. Hess · 5 shared papers, 2011–2012 · strength 0.17
  15. Yongwei Wang · 2 shared papers, 2019–2020 · strength 0.16
  16. Ping Chang · 4 shared papers, 2011–2014 · strength 0.15
  17. Hongwei Tang · 4 shared papers, 2011–2012 · strength 0.13
  18. Bei Sun · 1 shared paper, 2020 · strength 0.08
  19. Min Li · 1 shared paper, 2020 · strength 0.08
  20. Shaofan Weng · 2 shared papers, 2014 · strength 0.08
  21. Bei Sun · 1 shared paper, 2019 · strength 0.07
  22. Milind M. Javle · 1 shared paper, 2014 · strength 0.05
  23. Yumin Li · 1 shared paper, 2014 · strength 0.04
  24. Jin Wang · 1 shared paper, 2014 · strength 0.04
  25. Subrata Sen · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.